CADX Financial Facts
Total other expense, net: 6.58MInterest expense: -1.1M
See Full Income Statement
Cash and cash equivalents: 60.5M
Accounts receivable, net: 8.91M
See Full Balance Sheet
Earnings History for Cadence Pharma (CADX)
|
Expand Research on CADX
| Next EPS Date | 5/5/11 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -20.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/10  |
Q310 | -$0.23 | -$0.24 | +$0.01 | N/A | N/A | N/A / N/A | N/A | -10.3% | Details | |
| 3/4/11 |
 |
Q410 | -$0.33 | -$0.34 | +$0.01 | N/A | $290K | N/A / N/A | N/A | -4.4% | Details |
| 5/5/11 |
|
Q111 | N/A | -$0.33 | N/A | N/A | $710K | N/A / N/A | N/A | N/A | N/A |
| 8/3/11 |
Q211 | -$0.30 | -$0.38 | +$0.08 | $1.7M | $1.62M | N/A / N/A | N/A | -16.2% | Details | |
| 11/3/11 |
|
Q311 | -$0.34 | -$0.36 | +$0.02 | N/A | $4.17M | N/A / N/A | N/A | +25.3% | Details |
| 3/12/12 | Q411 | -$0.28 | -$0.27 | -$0.01 | $5.9M | $6.88M | N/A / N/A | N/A | +92% | Details | |
| 5/3/12 | Q112 | -$0.27 | -$0.22 | -$0.05 | $8M | $8.93M | N/A / N/A | = | +99.4% | Details | |
| 11/5/12 |
Q312 | -$0.19 | -$0.19 | $0.00 | $13.9M | $14.16M | N/A / N/A | N/A | +102.8% | Details |
